VCEL logo

Vericel Corporation


VCEL: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.


Show VCEL Financials

Consumer Interest
SEC Filings

Recent trades of VCEL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VCEL's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Cell seeding device and method Jul. 03, 2018
  • Patent Title: Mixed cell populations for tissue repair and separation technique for cell processing Aug. 16, 2016
Government Contracts

Federal grants, loans, and purchases


Number of mentions of VCEL in WallStreetBets Daily Discussion


Recent insights relating to VCEL

CNBC Recommendations

Recent picks made for VCEL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VCEL

Corporate Flights

Flights by private jets registered to VCEL